Financial News
Latest News about BNTX
Recent news which mentions BNTX
Pfizer, BioNTech Launch Omicron-Targeted COVID-19 Vaccine Trial
January 25, 2022
From Benzinga
The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data
January 25, 2022
From Benzinga
Here's What to Look For in Pfizer's Upcoming Earnings Report
January 25, 2022
From Motley Fool
Why Vaccine Stocks Like Moderna and Novavax Tumbled (Again) Today
January 24, 2022
From Motley Fool
Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows
January 24, 2022
From Benzinga
Arcturus Therapeutics' COVID-19 Booster Clinical Trial Show Encouraging Neutralizing Antibody Responses
January 24, 2022
From Benzinga
Where Will BioNTech Be in 3 Years?
January 24, 2022
From Motley Fool
From Benzinga
Why Novavax Stock Tumbled on Thursday
January 20, 2022
From Motley Fool
From Motley Fool
From Benzinga
Sputnik V Associated With Higher Antibody Levels Against Omicron Than Pfizer, Study Shows: Reuters
January 20, 2022
From Benzinga
South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing
January 20, 2022
From MarketWatch
From MarketWatch
Booster Shots Might Not Be Enough to Beat Omicron, According to Some Nanotech Experts
January 19, 2022
From Benzinga
2 Top Healthcare Stocks Ready for a Bull Run
January 19, 2022
From Motley Fool
Could Novavax Go Parabolic?
January 19, 2022
From Motley Fool
Why BioNTech, Moderna, and Novavax Stocks Are Sinking Today
January 18, 2022
From Motley Fool
Why Moderna, Pfizer, BioNTech And Novavax Shares Are Falling Today
January 18, 2022
From Benzinga
Omicron cases seem to have peaked in northeastern states, but national case tally is still at record levels and hospitals are slammed
January 18, 2022
From MarketWatch
Brace for a volatile 2022, but cling to this tech stalwart when the storm comes, says investment advisor
January 18, 2022
From MarketWatch
4 Shots Of Pfizer COVID-19 Vaccine Not Enough To Prevent Omicron Infection, Say Israeli Researchers
January 18, 2022
From Benzinga
Preliminary Israeli study shows fourth COVID booster doesn’t stop omicron infections
January 18, 2022
From MarketWatch
3 Top Dividend Stocks to Buy Now
January 16, 2022
From Motley Fool
Is the COVID-19 Investing Boom Over?
January 15, 2022
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 14, 2022
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
